The Preliminary Analysis of Sentinel Lymph Node Biopsy Guided by 99mTc-Rituximab in Patients with Breast Cancer.

Conclusions: Sentinel lymph node biopsy with 99mTc-Rituximab has high success rate and low false-negative rate. It is beneficial to the choice of individual treatment schedule. It can reduce unnecessary lymph node dissection and avoid sugery complication and has a high application value.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Translational Image Guided Source Type: research